Drug resales get scrutiny
The Wall Street Journal, March 22, 2012
Some drug distributors are setting up fake pharmacies that allow them to obtain and then artificially raise the prices for cancer drugs and other medicines that are in short supply, according to letters written by lawmakers Wednesday. Lawmakers are looking into what they claim is a "gray market" for scarce prescription drugs that has emerged in recent months. Three Democrats on Wednesday sent letters to pharmacies that they say appear to have sold drugs in short supply to drug wholesalers which sold them at a sharp markup instead of dispensing the drugs to patients.
Most Viewed
Most Emailed
- Healthcare Leaders Seek Strategic Sweet Spot
- 3 Reasons Wellness Programs Fail
- CMS Issues Health Insurance Exchange Proposed Rules
- Patients Shoulder Nearly 25% of Medical Bills
- ACOs Widespread, Yet Challenged
- MGMA: Physician Compensation Increasingly Based on Quality Measures
- HFMA: Patient Financial Interaction Guidelines Sharpened
- 6 CNO-to-CEO Strategies
- PwC: Pace of Rising Medical Costs Slowing
- Data Collaborative Taps Predictive Analytics to Coordinate Care
